Skip to main content
. Author manuscript; available in PMC: 2014 Jun 18.
Published in final edited form as: Diabetologia. 2010 Dec 29;54(4):935–944. doi: 10.1007/s00125-010-1984-5

Fig. 2.

Fig. 2

Glucose turnover assessed by euglycaemic–hyperinsulinaemic clamps. a Endogenous glucose production, (b) glucose infusion rate, (c) insulin-stimulated hepatic glucose output and (d) whole-body glucose turnover in Trib3 ASO treated (white bars; control ASO, grey bars) animals with and without additional BADGE treatment. Values are given as mean±SE, n=12 per group, n=6–8 per group for BADGE treated animals. **p<0.01